MacDonald T M, Wei L
Medicines Monitoring Unit, Department of Clinical Pharmacology and Therapeutics, Ninewells Hospital and Medical School, DD1 9SY, Dundee, UK.
Lancet. 2003 Feb 15;361(9357):573-4. doi: 10.1016/s0140-6736(03)12509-3.
Treatment with ibuprofen might limit the cardioprotective effects of aspirin. We aimed to assess whether patients with known cardiovascular disease who take low-dose aspirin and ibuprofen have increased risk of cardiovascular mortality. We studied 7107 patients who were discharged after first admission for cardiovascular disease between April, 1989, and April, 1997, and who were prescribed low-dose aspirin (<325 mg/day) and survived for at least 1 month. Compared with those who used aspirin alone, patients taking aspirin plus ibuprofen had an increased risk of all-cause mortality (adjusted hazard ratio 1.93, 95% CI 1.30-2.87, p=0.0011) and cardiovascular mortality (1.73, 1.05-2.84, p=0.0305). Our finding lends support to the hypothesis that ibuprofen may interact with the cardioprotective effects of aspirin, at least in patients with established cardiovascular disease.
使用布洛芬进行治疗可能会限制阿司匹林的心脏保护作用。我们旨在评估服用低剂量阿司匹林和布洛芬的已知心血管疾病患者心血管死亡风险是否增加。我们研究了1989年4月至1997年4月期间因心血管疾病首次入院后出院、服用低剂量阿司匹林(<325毫克/天)且存活至少1个月的7107名患者。与仅使用阿司匹林的患者相比,服用阿司匹林加布洛芬的患者全因死亡风险增加(调整后的风险比为1.93,95%置信区间为1.30 - 2.87,p = 0.0011),心血管死亡风险增加(1.73,1.05 - 2.84,p = 0.0305)。我们的发现支持了这样一种假设,即布洛芬可能会与阿司匹林的心脏保护作用相互作用,至少在已患有心血管疾病的患者中如此。